Cognitive Impairment, Dementia
Conditions
Keywords
dementia, cognitive impairment, disability, intervention, elderly, lifestyle counseling
Brief summary
This multi-center (6 sites: Helsinki, Kuopio, Oulu, Seinäjoki, Turku, Vantaa) intervention study aims to prevent cognitive impairment, dementia and disability in 60-77 year old persons at an increased dementia risk. The 2-year multi-domain life-style intervention includes nutritional guidance, exercise, cognitive training, increased social activity, and intensive monitoring and management of metabolic and vascular risk factors. The primary outcome is cognitive impairment measured by a sensitive Neuropsychological Test Battery (NTB), and Stroop and Trail Making tests to capture early cognitive impairment typical for both Alzheimer's disease and vascular dementia. We hypothesize that the multi-domain intervention will reduce cognitive impairment in the study group compared to the control group during the initial 2-year intervention period and reduce dementia incidence after the extended follow-up (until at least 300 participants have developed dementia).
Interventions
Individual counseling sessions and group meetings will be organized.
Guided muscle strength training and aerobic exercise.
Cognitive training will be implemented through 8 group sessions lead by a psychologist and a computer-based cognitive training program available to participants via the internet.
Monitoring and maintenance of metabolic and vascular risk factors
Sponsors
Study design
Eligibility
Inclusion criteria
* aged 60-77 years * dementia Risk Score 6 points or more * fulfillment of at least one of the following CERAD criteria: i) MMSE: 20-26 points ii) word list memory task (3x10 words): 19 words or less iii) delayed recall: 75% or less
Exclusion criteria
* malignant diseases * dementia * substantial cognitive decline * major depression * symptomatic cardiovascular disease * revascularisation within 1 year * severe loss of vision, hearing or communicative ability * other conditions inhibiting from safe engagement in the prescribed intervention as judged by the study physician * other conditions preventing from cooperation as judged by the study physician
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cognitive impairment assessed with a Neuropsychological Test Battery, and Stroop and Trail Making tests. | 2 years |
Secondary
| Measure | Time frame |
|---|---|
| Disability will be assessed using the ADCS-ADL scale | 2 years |
| Quality of Life will be assessed using the RAND-36 and 15D questionnaires. | 2 years |
| Utilization of health resources will be assessed using questionnaire and register data. | 2 years |
| Depressive symptoms will be assessed using the Zung depression scale. | 2 years |
| Vascular and metabolic morbidity and mortality will be assessed through questionnaire and register data. | 2 years |
| Changes in dietary biomarker levels will be assessed through laboratory testing. | 2 years |
| Vascular and metabolic risk factors will be assessed with blood pressure and anthropometric measurements, and laboratory analyses of metabolic biomarkers. | 2 years |
Countries
Finland